tirzepatide doctor Before You Inject: Why You Must See a for Semaglutide & Tirzepatide Safety | Why Physician

24 A short-term, double-blind clinical study involving 426 patients with peripheral neuropathy of different etiologies, showed statistically meaningful differences between the ALC and placebo groups in terms of mean conduction velocity improvement

Remain on 3mg for the full month before moving to 7mg, even if side effects are minimal

Patients have reported a number of side effects, including nausea, vomiting, diarrhea, stomach pain, and constipation

review papers summarise the design rationale without publishing the full sequence (PMID 39515565)

However, it is important to note that further research and high-quality clinical trials are needed to establish the true efficacy of natural GLP-1 inducers and to determine if their effectiveness is comparable to that of GLP-1 drugs